Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TNF | P01375 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7030321 | 0.99 | LMNA (0.45) | LMNAALDH1A1KDM4EHSD17B10CYP4F2 | |
| Hydrochloric Acid SCHEMBL8517214 | 0.88 | TBXAS1 (0.41) | LMNAALDH1A1CYP4F2CYP4A11CYP1A2 | |
| Hydrochloric Acid SCHEMBL7021156 | 0.77 | ALDH1A1 (0.42) | ALDH1A1KDM4EHSD17B10SMN1; SMN2 | |
| SCHEMBL7028443 | 0.72 | KDM4E (0.33) | LMNAALDH1A1KDM4EMAPT | |
| SCHEMBL11716159 | 0.70 | SMN1; SMN2 (0.43) | ALDH1A1KDM4EHSD17B10MAPK1L3MBTL1 | |
| SCHEMBL13125915 | 0.64 | ALDH1A1 (0.61) | LMNAALDH1A1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL11418576 | 0.64 | POLB (0.64) | ALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL20268795 | 0.63 | MAPK1 (0.73) | ALDH1A1KDM4EHSD17B10MAPK1CYP1A2 | |
| SCHEMBL11529284 | 0.63 | ALDH1A1 (0.42) | LMNAALDH1A1KDM4EHSD17B10CYP4F2 | |
| SCHEMBL25307852 | 0.62 | CYP4F2 (0.43) | LMNAALDH1A1KDM4EHSD17B10CYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0889884-B1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON INC (US) | 2003-01-29 | — | — | EP | claimed |
| US-6380192-B1 | FOR INHIBITING NONENZYMATIC CROSS-LINKING (PROTEIN AGING) | ALTEON, INC. | 2002-04-30 | — | — | US | claimed |
| EP-0889884-B1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON INC (US) | 2003-01-29 | — | — | EP | disclosed |
| US-6380192-B1 | FOR INHIBITING NONENZYMATIC CROSS-LINKING (PROTEIN AGING) | ALTEON, INC. | 2002-04-30 | — | — | US | disclosed |
| US-6060470-A | Triazine compounds and methods of use therefor | ALTEON, INC. | 2000-05-09 | — | — | US | disclosed |
| US-5932578-A | CAPABLE OF INHIBITING THE FORMATION OF ADVANCED GLYCOSYLATION ENDPRODUCTS OF TARGET PROTEINS. FOOD SPOILAGE AND ANIMAL PROTEIN AGING CAN BE TREATED. | ALTEON INC. (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0889884-A1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON, INC. (US) | 1999-01-13 | — | — | EP | disclosed |
| WO-1997035849-A1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON INC. (US) | 1997-10-02 | — | — | WO | disclosed |